PROMES: A Clinical Study in Which Researchers Want to Learn More About the Safety Profile of MESIGYNA (Norethisterone Enantate 50 mg and Estradiol Valerate 5 mg) Used as a Medication to Prevent Pregnancy for Adult Women in Reproductive Age in the Peruvian Population at the Outpatient Clinic.
Condition: Contraceptive Effectiveness Intervention: Drug: Norethisterone enantate/estradiol valerate (Mesigyna, BAY98-7040) Sponsor: Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Estradiol | Learning | Peru Health | Pregnancy | Research | Study | Universities & Medical Training | Women